Alon Ben-Noon insider trades

Open-market stock purchases and sales by Alon Ben-Noon, Chief Executive Officer at NeuroSense Therapeutics Ltd, from SEC Form 4 filings since Jun 16, 2026.

Recent trades

DateStockTradeValue
Jun 16, 2026NRSN NeuroSense Therapeutics LtdBought$200K

Companies traded

  • NRSN NeuroSense Therapeutics Ltd: 1 buy, last Jun 16, 2026

Get free alerts when Alon Ben-Noon files a new trade →